he can be whatever he wants to be fact is they are awaiting response for a fda approval for clinical trials in a huge industry. and today i've got 220 million reasons to think. many people are very positive about this stock
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.